Dr Robert Grundy has spent over 25 years in Pharma and Biotech beginning in drug discovery and development in large Pharma at Schering-Plough and GlaxoSmithKline. Rob served as CSO with Cerebricon before joining Almac Discovery in 2008. In 2014 Rob founded Anglezarke Life Sciences, a commercialisation and growth strategy consultancy. Rob has served as CEO of CIGA Healthcare, Health Innovation Research Alliance Northern Ireland and, up until January 2025 Intelligent OMICS. Rob has held or holds visiting and honorary lectureships at King’s College London and Queen’s University Belfast. Rob formally chaired Matrix, the Science and Technology policy panel for the Northern Ireland Government and represented Northern Ireland on the Chief Scientific Advisors Network for the UK between 2022 and 2024. Since February 2025 he has served as Director of Innovation Partnerships at Catalyst, Northern Ireland’s Science Park.
-
Name:Dr Rob Grundy MBE
-
Job Title:Northern Ireland co-chair